QUALITY AGREEMENT for TRU-016 between TRUBION PHARMACEUTICALS, INC. and LONZA SALES AGQuality Agreement • November 5th, 2009 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Quality Agreement (“Quality Agreement”) is dated effective as of November ___, 2008, and it defines the roles and responsibilities for the quality operations between TRUBION PHARMACEUTICALS, INC. (“Trubion” and “Customer”) and LONZA SALES AG (“Lonza”) with respect to the manufacture of Customer’s product commonly referred to as TRU-016 under that certain Manufacturing Services Agreement dated as of November 21, 2005, between Trubion and Lonza Biologics, Inc. (“Biologics”) (as amended and novated, the “MSA”). Concurrently herewith, the parties are also entering into an amendment to manufacturing services in order to amend the MSA as appropriate for the manufacture of TRU-016 (the “Amendment”). Lonza is the successor in interest to Biologics under the MSA pursuant to that certain Novation Agreement effective as of January 1, 2007, among Trubion, Lonza and Biologics.
AMENDMENT between TRUBION PHARMACEUTICALS, INC. and LONZA SALES AG (successor in interest to Lonza Biologics, Inc. by way of novation) to MANUFACTURING SERVICES AGREEMENT Dated November 21, 2005Manufacturing Services Agreement • November 5th, 2009 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
THIS AMENDMENT TO MANUFACTURING SERVICES AGREEMENT (“Amendment”) is made effective as of December 5, 2008 (the “Effective Date”) and is made between
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • November 5th, 2009 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • California
This Collaboration and License Agreement (this “Agreement”) is entered into as of August 27, 2009 (the “Signing Date”), by and between Facet Biotech Corporation, a Delaware corporation having a principal place of business at 1500 Seaport Blvd., Redwood City, California 94063 (“Facet”) and Trubion Pharmaceuticals, Inc., a Delaware corporation having a principal place of business at 2401 4th Avenue, Suite 1050, Seattle, Washington 98121 (“Trubion”). Facet and Trubion may each be referred to herein individually as a “Party” and collectively as the “Parties”.
SECOND AMENDMENT between TRUBION PHARMACEUTICALS, INC. and LONZA SALES AG (successor in interest to Lonza Biologics, Inc. by way of novation) to MANUFACTURING SERVICES AGREEMENT dated November 21, 2005Manufacturing Services Agreement • November 5th, 2009 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT TO MANUFACTURING SERVICES AGREEMENT (“Second Amendment”) is made effective as of April 3, 2009 (the “Effective Date”) and is made between
